ExitHealthcare
Angelini Ventures sells Noctrix Health to ResMed
The deal brings Nidra, an FDA-authorized non-invasive therapy for moderate-to-severe restless legs syndrome, into a broader sleep health and respiratory care business.
- Target
- Noctrix Health
- Seller
- Angelini Ventures
- Source
- GlobeNewswire